Therefore, pridopidine may ameliorate the TFEB transport deficit in the C9orf72 subtype of amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTD), where the mutation damages the nucleocytoplasmic transport of TFEB (Wang et al., 2022). This evidence concerns the gene TFEB and amyotrophic lateral sclerosis.